CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts.
Ontology highlight
ABSTRACT: Physiological bone remodeling requires that bone formation by osteoblasts be tightly coupled to bone resorption by osteoclasts. However, relatively little is understood about how this coupling is regulated. Here, we demonstrate that modulation of NF-κB signaling in osteoclasts via a novel activity of charged multivesicular body protein 5 (CHMP5) is a key determinant of systemic rates of bone turnover. A conditional deletion of CHMP5 in osteoclasts leads to increased bone resorption by osteoclasts coupled with exuberant bone formation by osteoblasts, resembling an early onset, polyostotic form of human Paget's disease of bone (PDB). These phenotypes are reversed by haploinsufficiency for Rank, as well as by antiresorptive treatments, including alendronate, zolendronate, and OPG-Fc. Accordin
SUBMITTER: Greenblatt MB
PROVIDER: S-EPMC4516796 | biostudies-literature | 2015 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA